Fermata Advisors’s Boston Scientific BSX Stock Holding History

Fermata Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,846	Closed	-$287K	–	239
2025 Q1	$287K	Buy	+2,846	New	+$287K	0.05%	222

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fermata Advisors's BSX Position: Q2 2025 in Review

Fermata Advisors sold out of Boston Scientific (BSX) in Q2 2025, closing a stake of 2,846 shares — an estimated $287K sold.

Fermata Advisors first reported a position in BSX in Q1 2025 and held it in 1 quarter. The position peaked at $287K in Q1 2025. 1,687 funds tracked by Wall St. Rank hold BSX as of Q2 2025.

Fermata Advisors reported no remaining Boston Scientific position as of Q2 2025 after selling out during the quarter.
Fermata Advisors sold 2,846 Boston Scientific shares in Q2 2025, an estimated $287K.
Fermata Advisors first reported a position in Boston Scientific in Q1 2025 and held it in 1 quarter.
Fermata Advisors's Boston Scientific position peaked at $287K in Q1 2025.
1,687 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2025.

Based on Fermata Advisors's 13F filing for Q2 2025, filed 9 Jul 2025.